Priority Date: 19.07.12 (US 201261673630P)

ANTIBODY SPECIFIC FOR CD22 AND METHODS OF USE THEREOF

  • Application ID: EP13820140
  • Status: GRANT OF PATENT INTENDED

Attorneys

operating since 2006
Headquarter in Munich and 2 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing
operating since 1890
Headquarter in London and 4 offices
active in Legal Services

Specialization

This patent has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) Mewburn Ellis LLP and Grund Intellectual Property Group are specialized in A61. Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 19.07.2012 - Priority Date (US 201261673630P)
  • 23.01.2014 - Publication A1 (WO2014014821)
  • 27.05.2015 - Publication A1 (EP2874650)

IPC Classification